Houston biotech cos. begin clinical trials for cancer, Covid-19 treatments By: Houston Business Journal via Business Journals October 20, 2021 at 17:46 PM EDT Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
